|
H10: additional manufacturer narrative: the subject device is not available for evaluation, as it remains implanted in the patient.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
It was reported and learned from medical records that a patient with a 21mm 8300ab aortic valve underwent a valve-in-valve procedure after an implant duration of 3 years, 3 months due to moderate aortic stenosis with peak gradient of 51mmhg, mean gradient of 34mmhg, ava 0.67cm2 and ef of 40-45%.The patient presented with chest pain and dyspnea.The tavr was successfully performed with a 23mm 9755rsl valve without complications.The patient was discharged on pod#1.
|
|
H10: additional manufacturer narrative: updated sections: d4 (expiration date), g3, g6, h2, h4, h6 (type of investigation, investigation findings, and investigation conclusions).Stenosis is a common manifestation of bioprosthetic valve and valved conduit dysfunction and has many potential root causes, including structural valve deterioration (svd), non-structural valve dysfunction (nsvd), endocarditis and/or thrombosis.Bioprosthetic device stenosis is typically related to patient and/or procedural factors and is not typically an indication of a device malfunction related to a manufacturing deficiency.Device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.The instructions for use (ifu) have been reviewed, and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.The reported type of event is included in the ifu.The most likely root cause is patient factors, including hyperlipidemia (hld), diabetes mellitus (dm), chronic kidney disease (ckd).
|